Teva Pharmaceutical Statistics
Total Valuation
TEVA has a market cap or net worth of $21.12 billion. The enterprise value is $37.99 billion.
Important Dates
The next confirmed earnings date is Wednesday, November 6, 2024, before market open.
| Earnings Date | Nov 6, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
TEVA has 1.13 billion shares outstanding. The number of shares has increased by 0.85% in one year.
| Shares Outstanding | 1.13B |
| Shares Change (YoY) | +0.85% |
| Shares Change (QoQ) | +0.89% |
| Owned by Insiders (%) | 0.59% |
| Owned by Institutions (%) | 68.04% |
| Float | 1.13B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | 7.29 |
| PS Ratio | 1.29 |
| Forward PS | 1.28 |
| PB Ratio | 3.32 |
| P/FCF Ratio | 31.10 |
| PEG Ratio | 15.41 |
Financial Ratio HistoryEnterprise Valuation
The stock's EV/EBITDA ratio is 8.32, with an EV/FCF ratio of 55.95.
| EV / Earnings | n/a |
| EV / Sales | 2.33 |
| EV / EBITDA | 8.32 |
| EV / EBIT | 10.90 |
| EV / FCF | 55.95 |
Financial Position
The company has a current ratio of 0.89, with a Debt / Equity ratio of 2.88.
| Current Ratio | 0.89 |
| Quick Ratio | 0.46 |
| Debt / Equity | 2.88 |
| Debt / EBITDA | 4.03 |
| Debt / FCF | 27.87 |
| Interest Coverage | 3.40 |
Financial Efficiency
Return on equity (ROE) is -10.51% and return on invested capital (ROIC) is 8.04%.
| Return on Equity (ROE) | -10.51% |
| Return on Assets (ROA) | 5.16% |
| Return on Capital (ROIC) | 8.04% |
| Revenue Per Employee | $430,372 |
| Profits Per Employee | -$11,968 |
| Employee Count | 37,851 |
| Asset Turnover | 0.39 |
| Inventory Turnover | 2.05 |
Taxes
In the past 12 months, TEVA has paid $606.00 million in taxes.
| Income Tax | 606.00M |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +107.34% in the last 52 weeks. The beta is 0.87, so TEVA's price volatility has been lower than the market average.
| Beta (5Y) | 0.87 |
| 52-Week Price Change | +107.34% |
| 50-Day Moving Average | 18.02 |
| 200-Day Moving Average | 15.81 |
| Relative Strength Index (RSI) | 60.40 |
| Average Volume (20 Days) | 5,386,306 |
Short Selling Information
| Short Interest | 19.91M |
| Short Previous Month | 30.34M |
| Short % of Shares Out | 1.77% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 3.41 |
Income Statement
In the last 12 months, TEVA had revenue of $16.29 billion and -$453.00 million in losses. Loss per share was -$0.40.
| Revenue | 16.29B |
| Gross Profit | 8.06B |
| Operating Income | 3.49B |
| Pretax Income | 131.00M |
| Net Income | -453.00M |
| EBITDA | 4.57B |
| EBIT | 3.49B |
| Loss Per Share | -$0.40 |
Full Income StatementBalance Sheet
The company has $2.26 billion in cash and $18.92 billion in debt, giving a net cash position of -$16.66 billion or -$14.71 per share.
| Cash & Cash Equivalents | 2.26B |
| Total Debt | 18.92B |
| Net Cash | -16.66B |
| Net Cash Per Share | -$14.71 |
| Equity (Book Value) | 6.56B |
| Book Value Per Share | 5.61 |
| Working Capital | -1.41B |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was $1.17 billion and capital expenditures -$489.00 million, giving a free cash flow of $679.00 million.
| Operating Cash Flow | 1.17B |
| Capital Expenditures | -489.00M |
| Free Cash Flow | 679.00M |
| FCF Per Share | $0.60 |
Full Cash Flow StatementMargins
Gross margin is 49.50%, with operating and profit margins of 21.39% and -2.78%.
| Gross Margin | 49.50% |
| Operating Margin | 21.39% |
| Pretax Margin | -0.88% |
| Profit Margin | -2.78% |
| EBITDA Margin | 28.02% |
| EBIT Margin | 21.39% |
| FCF Margin | 4.17% |
Dividends & Yields
TEVA does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -0.85% |
| Shareholder Yield | -0.85% |
| Earnings Yield | -2.14% |
| FCF Yield | 3.22% |
Dividend DetailsAnalyst Forecast
The average price target for TEVA is $19.63, which is 5.31% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $19.63 |
| Price Target Difference | 5.31% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 8 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsStock Splits
The last stock split was on July 1, 2004. It was a forward split with a ratio of 2:1.
| Last Split Date | Jul 1, 2004 |
| Split Type | Forward |
| Split Ratio | 2:1 |
Scores
TEVA has an Altman Z-Score of 0.37 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 0.37 |
| Piotroski F-Score | 6 |